Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| antigen level prostate specific |
|
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and In five of the seven total studies, subject selection was influenced by prostate-specific antigen (PSA) levels. We examined the association and possible Prostate-Specific Antigen Levels Decrease With High Body Mass Index Although researchers found that PSA levels decreased with high body mass index, race, body mass index, and height were linked independently with PSA and PSA REMAINS BEST INDICATOR OF PROSTATE CANCER PROGRESSION that measuring the blood protein prostate-specific antigen (PSA) may not be âœIn our study, PSA levels measured before prostate removal surgery were Infectious Agents and Cancer | Full text | Prostate-specific Game X, Vincendeau S, Palascak R, Milcent S, Fournier R, Houlgatte A: Total and Free Serum Prostate Specific Antigen Levels during the First Month of Acute Higher prostate-specific antigen levels predict improved survival These graphs illustrate Kaplan-Meier estimates of overall survival according to prostate-specific antigen (PSA) levels at the start of chemotherapy for LEE BIOSOLUTIONS (PSA) HUMAN PROSTATE SPECIFIC ANTIGEN HIGH PURITY Higher than normal levels of human tumor marker Prostate Specific Antigen(PSA) are associated with both localized and metastatic prostate cancer (CaP). Questions and Answers About the Prostate-Specific Antigen (PSA) Test PSA is a protein produced by the cells of the prostate gland. The prostate-specific antigen (PSA) test measures the level of PSA in the blood. Prostate Specific Antigen - Cancer Information (Cancers, Symptoms What other conditions can cause an abnormal PSA level? The prostate specific antigen (PSA) is a substance produced by certain cells in the prostate CancerNetwork: Terris MK, Haney DJ, Johnstone IM, et al: Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, Impact of prostate-specific antigen level and prostate volume as Objective To report the 3-year results and analyse whether total prostate-specific antigen (tPSA) levels and prostate volume before treatment can predict No Job Name Results: Prostate-specific antigen levels decreased with increasing BMI (P .. Table 2 Mean prostate-specific antigen level by body mass index and age JAMA -- Abstract: Variation of Serum Prostate-Specific Antigen Variation of Serum Prostate-Specific Antigen Levels. An Evaluation of Year-to-Year Fluctuations. James A. Eastham, MD; Elyn Riedel, MA; Peter T. Scardino, PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING Prostate-specific antigen (PSA) test is a test that measures the level of PSA in the blood. PSA is used to screen for prostate cancer. eMedicine - Prostate-Specific Antigen : Article by Stanley A Benson MC, Whang IS, Olsson CA, et al: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate Prostate specific antigen BACKGROUND: To determine the impact of various preoperative serum prostate specific antigen (PSA) levels in the range from 0.1 to 10 ng/ml on pathological Prostate-Specific Antigen (PSA) A prostate-specific antigen (PSA) test measures the amount of of men are turning to testosterone supplements to maintain energy levels as they age. Prostate specific antigen - Wikipedia, the free encyclopedia "Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter". N Engl J Med 350 (22): 2239-46. PMID 15163773. Prostate-Specific Antigen Levels as a Predictor of Lethal Prostate Prostate-Specific Antigen Levels, Prostate-Specific Antigen Kinetics, and Prostate Cancer Prognosis: A Tocsin Calling for Prospective Studies The Prostate-Specific Antigen (PSA) Test: Q & A - National Cancer Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. New England Journal of Medicine 2004; |
| antigen level prostate specific |
|
exam humor not prostate cancer prostate proton therapy cancer prostate proton treatment anemia prostate cancer |